Stanford University
Showing 901-1,000 of 37,122 Results
-
Fernando Amaral Carnauba
Assistant Professor (Teaching) of Education
BioFernando Carnauba received his doctoral degree in Mathematics Education from Teachers College, Columbia University. He earned an MA in Economics at the University of São Paulo and an MA in Mathematics Education at Teachers College. Fernando currently works on deepening teacher education programs with a network of 20 Brazilian universities. In partnership with the Lemann Center at Stanford GSE, this network develops and offers professional development programs in Mathematics and Science to public school teachers in Brazil.
-
Christian Ambler, Ph.D.
Stanford Children S Health - Neuropsychologist, IT Services
BioDr. Ambler is a Neuropsychologist with interests in brain injury, executive dysfunction, ADHD, autism, learning disabilities, and neuropsychological sequelae of medical disorders. He completed his internship at Santa Clara Valley Medical Center and fellowship at Children’s Health Council.
chambler@stanfordchildrens.org -
Michelle Ameri, BA, RVT
Affiliate, Pediatrics - Cardiology
BioMichelle received a BA in Biology from the University of North Carolina at Asheville. Immediately after graduation, she entered the veterinary field as an assistant and thrived in the field, eventually receiving her Registered Veterinary Technician license in 2001. Prior to working at Stanford, she was the head nurse at Peninsula Equine Medical Center in Menlo Park where her duties included everything from front office work to ICU patient care to administering and monitoring anesthesia on 1000+ lb horses. She also has been an Adjunct Instructor at Foothill College in Los Altos, CA for the Veterinary Technician Program.
Since joining the Rabinovitch-Bland Lab in 2004, her role has been overseeing the day-to-day needs of the laboratory and staff. In addition to providing administrative support to the PI's and researchers, she oversees the financial and regulatory aspects of our program. Michelle really enjoys being part of a team. Her 25+ years in the veterinary field has made her proficient at working with doctors, students, and staff members. Her degree and background in the medical field are useful tools to bring to the table, and she prides herself on being proactive, organized, and having a positive attitude. When not at Stanford, you can find her at the beach, hiking with her dog, or riding her horse. -
Afshine Amidi
Adjunct Lecturer, Institute for Computational and Mathematical Engineering (ICME)
BioTeaching the following classes with my twin brother Shervine:
- CME 295: Transformers & Large Language Models (https://cme295.stanford.edu/)
- CME 296: Diffusion & Large Vision Models (https://cme296.stanford.edu/)
Education: Ecole Centrale Paris, MIT -
Shervine Amidi
Adjunct Lecturer, Institute for Computational and Mathematical Engineering (ICME)
BioTeaching the following classes with my twin brother Afshine:
- CME 295: Transformers & Large Language Models (https://cme295.stanford.edu/)
- CME 296: Diffusion & Large Vision Models (https://cme296.stanford.edu/)
Education: Ecole Centrale Paris, Stanford University -
Manuel R. Amieva
Professor of Pediatrics (Infectious Diseases) and of Microbiology and Immunology
Current Research and Scholarly InterestsMy laboratory studies how bacteria colonize our bodies for long periods of time, and how interactions between bacteria and the epithelial surfaces of the gastrointestinal tract and skin may lead to disease. Epithelial surfaces are the first barrier against infection, but they also where our bodies meet and co-evolve with the microbial world.. Several of our studies have focused on the epithelial junctions as a target for bacterial pathogens. The host epithelium uses its epithelial junctions to form a tight but dynamic barrier with an external surface that is inhospitable to microbial attachment, secretes anti-microbial compounds, and has a rapid rate of self-renewal. The balance in the microbe-epithelial relationship results in silent commensalism or symbiosis; an imbalance results in diseases ranging from acute bacterial invasive disease to chronic ulcers or carcinoma.
Our laboratory has developed novel microscopy applications such as quantitative 3D confocal microscopy, electron microscopy, time-lapse imaging, microinjection and micromanipulation to visualize the interaction of pathogens with epithelial cells in culture and in animal and human tissues. Many of out studies focus on the gastric pathogen Helicobacter pylori, but we have also expanded our investigations to include the intestinal pathogens Listeria monocytogenes and Salmonella enterica, and the skin pathogen and colonizer Staphylococcus aureus. I believe that elucidating how microbes communicate with and alter our epithelial cells at a molecular level will be important for finding novel therapeutic targets to control mucosal colonization and prevent invasive disease.
Using this perspective, we have uncovered several novel concepts of how bacteria colonize and breach our epithelial surfaces. For example, we discovered that Helicobacter pylori target the intercellular junctions, and in particular that the virulence factor CagA affects junction assembly and cell polarity. This confers H. pylori the ability to extract nutrients and grow directly on the epithelial surface. We also found that these properties of CagA have consequences for cellular transformation of the epithelium. For instance, we showed that H. pylori affect the activity and state of epithelial stem cells in the stomach by colonizing the epithelial surface deep in the gastric glands. This gland-associated population is essential for pathological inflammation and hyperplasia in animal models, and confers significant colonization advantages to the bacteria. Our Listeria research uncovered a new mechanism and site where bacteria can breach the gastrointestinal epithelial barrier to invade. We found that Listeria find their receptor for invasion at sites of epithelial senescence, where the epithelial junctions undergo dynamic turnover. To study Salmonella and H. pylori we have developed a human organoid model to study their interactions with human gut epithelium in vitro. To study Staphylococcus aureus pathogenesis, we have developed methods to visualize infection at the scale of a single bacterial microcolony using an organoid culture system of human keratinocytes and fibroblasts that grow into a 3D skin-equivalent. We recently identified several proteins at the eptithelial junctions as host factors involved in the pathogenesis of one of Staphylococcus aureus major toxins. -
Nancy Ammar
Ph.D. Student in Electrical Engineering, admitted Autumn 2021
BioNancy Y. Ammar received her B.Sc. degree (with honors) in electronics and communication engineering from Ain Shams University, Cairo, Egypt, in 2019. In her senior year, she worked as an undergraduate Research Assistant in the Microwaves and Antenna Research Lab at Ain Shams University. She worked as an IC design consultant at Siemens EDA (Mentor Graphics previously).
-
Debbie Amoroso
Adm Assoc 3, Environmental Health and Safety (EH&S)
Current Role at StanfordStanford ChemTracker Administrator
Hazardous Materials Management Coordinator for EHS Hazardous Materials Management Program
Administrative Associate for EHS Research Safety Program -
Daniel Kwasi Amponsah
Affiliate, Department Funds
Fellow in Medicine - Med/Cardiovascular MedicineBioDr. Daniel Amponsah was born and raised in Loma Linda, California. He graduated with a BS in Biochemistry from Pacific Union College in Northern California and received his MD from Loma Linda University School of Medicine where he graduated AOA. He completed his internal medicine residency at Massachusetts General Hospital and was appointed the Simulation Chief his senior year. He is interested in pursuing an academic career in interventional cardiology with a focus on outcomes and health disparities. Prior research work has explored outcomes in ischemic time in patients with cardiogenic shock and STEMI with Dr. Anthony Hilliard, disparities in the management of aortic stenosis alongside Dr. Sammy Elmariah, defining type 2 MI using coronary CT with Dr. James Januzzi. He is presently engaged in assessing the potential applications of angiography-derived FFR and IMR across various coronary disease syndromes with Dr. Bill Fearon and investigating disparities in advanced structural interventions with Dr. Celina Yong.
-
Noor Amr
Ph.D. Student in Anthropology, admitted Autumn 2019
BioNoor Amr is a PhD candidate in Anthropology at Stanford University. She is currently writing her dissertation on the “church asylum” (Kirchenasyl) movement in Germany, paying attention to the relationship between sanctuary, religious difference, borders/migration, sovereignty, and political belonging. Her ethnographic research among churches and monasteries across Germany explores how Kirchenasyl—sanctuary from the state—becomes a means through which rejected asylum-seekers gain legibility as subjects worthy of legal recognition. Her broader theoretical interests include theories in political theology, religion/secularism, sanctuary and hospitality, histories of confinement, and the coloniality of asylum.
Prior to her doctoral work, Noor received a B.A. in Politics from Willamette University and an M.T.S. in Philosophy of Religion from Harvard Divinity School, where she was a Dean’s Fellow. -
Michael Amylon
Professor of Pediatrics (Hematology/Oncology) at the Lucile Salter Packard Children's Hospital, Emeritus
Current Research and Scholarly InterestsBone marrow transplantation (BMT) is a treatment modality which is being broadly applied to a growing number of disorders. Increasing success with BMT is offering improved survival to pediatric and adult patients with acute leukemia, chronic leukemia, lymphomas, and a variety of solid tumors as well as severe aplastic anemia.
-
Je Chun An
Postdoctoral Scholar, Education
BioJechun An is a postdoctoral scholar at Stanford University. Dr. An began his education career as a tenured elementary teacher in a rural area of Korea. After that, He worked as a secondary school principal qualification program coordinator at the National Academy for Educational Administrators at Seoul National University in Korea. Until 2024, He was a lab manager of a federally funded project (The Early Writing Project) to provide professional development for elementary teachers who have students with difficulties in writing. He served as a Post-Doctoral Associate at the Department of Educational Psychology, University of Minnesota, Twin-Cities (2024-2026). His major role was managing the data for two federally funded (Institute of Education Sciences; IES) projects that entail large-scale efficacy trials of educational technology focusing on literacy and mathematics.
Dr. An's research focuses on integrating literacy assessment into data-informed instructional systems to support teachers working with students who experience significant difficulties in literacy (reading and writing) and language. Ultimately, Dr. An's research goal is to develop equitable and instructionally useful approaches that improve literacy outcomes for diverse learners. He is currently involved in projects related to AI-supported coaching model development in Language to Literacy Research Lab (https://langlitlab.stanford.edu/) and computer-adaptive assessment of language and literacy skills (https://roar.stanford.edu/). -
Nadine Anaizi, PA-C
Affiliate, IT Services
BioNadine Anaizi, PA-C is a physician assistant at the Digestive Health Clinic at Stanford Health Care. She graduated from the Rochester Institute of Technology Physician Assistant program in 2009. Her areas of clinical practice is in gastroenterology with a focus in inflammatory bowel disease.
-
Kanwaljeet S. Anand
Professor of Pediatrics (Pediatric Critical Care) and of Anesthesiology, Perioperative and Pain Medicine
Current Research and Scholarly InterestsDr. Anand is a translational clinical researcher who pioneered research on the endocrine-metabolic stress responses of infants undergoing surgery and developed the first-ever scientific rationale for pain perception in early life. This provided a framework for newer methods of pain assessment, numerous clinical trials of analgesia/anesthesia in newborns, infants and older children. His research focus over the past 30+ years has contributed fundamental knowledge about pediatric pain/stress, long-term effects of pain in early life, management of pain, mechanisms for opioid tolerance and withdrawal. Current projects in his laboratory are focused on developing biomarkers for repetitive pain/stress in critically ill children and the mechanisms underlying sedative/anesthetic neurotoxicity in the immature brain. He designed and directed many randomized clinical trials (RCT), including the largest-ever pediatric analgesia trial studying morphine therapy in ventilated preterm neonates. He has extensive experience in clinical and translational research from participating in collaborative networks funded by NIMH, NINDS, or NICHD, a track-record of excellent collaboration across multiple disciplines, while achieving success with large research teams like the Collaborative Pediatric Critical Care Research Network (CPCCRN). He played a leadership roles in CANDLE (Condition Affecting Neuro-Development & Learning in Early infancy) and other activities of the Urban Child Institute and UT Neuroscience Institute. More recently, he led the NeoOpioid Consortium funded by the European Commission, which collected data from 243 NICUs in 18 European countries.
-
Neshanth Anand
Undergraduate, Vice Provost for Undergraduate Education
BioNeshanth Anand is an incoming undergraduate at Stanford University, planning to study computer science with a focus on design and human-computer interaction. He is particularly interested in accessible technology, ethical design, and the role of AI in shaping inclusive user experiences of users with disadvantaged capabilities and divergent learning scenarios.
-
Shivesh Anand
Postdoctoral Scholar, Cardiothoracic Surgery
BioDr. Shivesh Anand is an NWO Rubicon Postdoctoral Fellow in the Department of Cardiothoracic Surgery at Stanford University, specializing in tissue engineering and regenerative medicine. He completed his PhD at the MERLN Institute (Maastricht, Netherlands), where he applied biomaterials, biofabrication, and biomodulation strategies to develop nano-engineered scaffolds for tympanic membrane regeneration. His global research trajectory is deeply interdisciplinary, including research appointments at Harvard-MIT Health Sciences and Technology (United States), A*STAR (Singapore), IBEC Barcelona (Spain), and Aarhus University (Denmark). Currently focused on active regenerative engineering, he investigates how multimodal biophysical cues modulate cell fate and tissue regeneration.
-
Shreya Anand
Postdoctoral Scholar, Physics
BioLSST-DA Catalyst and KIPAC Rubin Fellow
-
Nidharshan Anandasivam
Affiliate, Department Funds
Fellow in Medicine - Med/NephrologyBioNidharshan Anandasivam is a fellow in the Stanford University Nephrology Fellowship Program. He received a Bachelor of Science in Biological Engineering at MIT, an MD from Yale School of Medicine, and an MBA from Yale School of Management. He completed his Internal Medicine Residency at University of Texas at Austin Dell Medical School.
-
Supphanat Anantachaisophon
Undergraduate, Energy Science & Engineering
BioAn undergraduate from Thailand. I am interested in Energy Science.
-
Christine Anastasiou, MD, MAS
Clinical Assistant Professor, Medicine - Immunology & Rheumatology
BioDr. Anastasiou is a board-certified, fellowship-trained rheumatologist with the Stanford Health Care Immunology and Rheumatology Clinic. She is also a clinical assistant professor in the Department of Medicine, Division of Immunology and Rheumatology at Stanford University School of Medicine.
Dr. Anastasiou specializes in diagnosing and treating patients with rheumatic diseases. She has a special interest in ankylosing spondylitis, systemic lupus erythematosus, rheumatoid arthritis, and idiopathic inflammatory myopathies.
Her scholarly work includes epidemiologic studies and clinical trials focused on improving safety and health outcomes for people with chronic rheumatic diseases. Dr. Anastasiou has served as an investigator and collaborator for clinical trials of new therapies to treat rheumatic disease. She is actively involved in medical education through developing and leading patient, medical student, resident, and fellow educational programs.
Dr. Anastasiou is a member of the American College of Rheumatology (ACR). She has published her research in peer-reviewed journals, including Arthritis Care & Research and Lupus Science & Medicine. She has delivered lectures and presentations across the country and abroad on various topics related to rheumatology.
